Clinic
4520 Dixie Road
Mississauga, Ontario L4W 1N2 Canada
Ph: 905.238.0599
Fax: 905.238.0682

Bioanalytical Lab
1290 Ellesmere Road
Toronto, Ontario M1P 2X9
Canada
Ph: 416.299.0012
Fax: 416.299.1239

Cetero’s Toronto facility has more than 20 years of clinical pharmacology and efficacy research experience and offers phase I-IV clinical trial management services to the pharmaceutical, biotechnology and generic industries.

The facility is designed to conduct clinical pharmacology studies, as well as having units specifically designed to conduct studies in patients with allergies and asthma. Toronto has completed more than 500 phase I-IV studies to-date.

The strong leadership and industry experience in Toronto allows projects to be taken from protocol development through final report. Toronto is recognized as a world leader in conducting allergy and asthma programs, both in our proprietary Environmental Exposure Chambers and traditional field or “day-in-the-park” programs.

Participant safety is paramount when conducting projects in special populations, and we are committed to safety, while meeting your objectives.

Toronto’s participant database consists of more than 35,000 active normal healthies, elderly, postmenopausals, smokers and special populations with asthma, allergy, arthritis, obesity and diabetes. In addition, our facility has access to more than eight million people in the metropolitan area.

Our comprehensive phase I-IV capabilities, including protocol writing, data management, PK/PD and biostatistics, bioanalytical, project management, site selection, monitoring and medical writing, allow us to provide you with a full-service program of clinical drug development.

Contact us today to discuss your next project at 877.7CETERO or toronto@cetero.com.

Toronto Study Experience  First-in-Human Single and multiple ascending dose in healthy participants or patients Proof-of-Concept Interaction Drug-drug, drug-food, and alcohol interaction Bioavailability Absolute bioavailability, bioequivalence Pharmacokinetic (PK) Dose proportionality, age/gender, renal or hepatic-impaired Pharmacodynamic (PD) Objective or subjective measures performed in-house or with patient diaries Environmental Exposure Chamber Study Experience Proof-of-Concept Efficacy Studies Onset and Duration of Action Nasal Delivery Studies Comparative Efficacy

Environmental Exposure Chamber (EEC) Models Non-Allergic Rhinitis Model Seasonal Allergen Chamber Models – Ragweed, Grass and Tree Perennial Allergen Chamber Models – Cat Allergen Room, Aerosolized Cat Allergen, Dust Mite Allergen Other Allergy and Asthma Models – Conjunctival, Nasal, Bronchial Allergen Challenges, Intracutaneous Testing Dry Eye Chamber Model